Piramal Pharma Limited has informed the Exchange regarding Change in Auditors of the company.
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma's Board has approved the appointment of Suresh Surana & Associates LLP, an Indian affiliate of global audit network RSM International, as the company's new Statutory Auditors for a five-year term, from the conclusion of the 5th AGM up to the 10th AGM in 2030. The Board also approved N L Bhatia & Associates, a peer-reviewed firm of practising company secretaries founded in 1995, as Secretarial Auditors for the same five-year period. Both appointments were made on the recommendation of the Audit Committee and are subject to shareholder approval at the upcoming AGM. Suresh Surana & Associates is part of RSM International, the 6th largest global audit network, with about 3,000 personnel across 13 Indian cities.
This is a routine governance update replacing the company's auditors with a globally affiliated firm; it is unlikely to have any material impact on the stock price or shareholder value, though shareholders will have the final say at the AGM.